Sol-Gel Technologies Ltd Announces 10-for-1 Reverse Stock Split to Boost Market Presence in Pharmaceuticals
Sol-Gel Technologies Ltd, a clinical-stage pharmaceutical company, has implemented a 10-for-1 reverse stock split to enhance its market presence and attract investors in the competitive healthcare sector.
3 minutes to read